Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Bod Australia is giving patients their first taste of its cannabis wafer
24 Jul 2018
Published by: Stockhead
Bod Australia kicks off phase 1 clinical trial for phytocomplex cannabis extract
24 Jul 2018
Published by: Small Caps
Momentum is building for medical cannabis drug subsidies says Bod Australia boss
18 Jun 2018
Published by: Stockhead
Listed cannabis group scores major deal with Good Price wholesaler
05 Jun 2018
Published by: Business News Australia
Bod Australia recruits Swisse director alongside growing medical cannabis trend
30 May 2018
Published by: Small Caps
Bod Australia sets the stage for marketing medical cannabis oil in Australia
12 Apr 2018
Published by: Small Caps
Bod Australia gains access to more than 2,000 pharmacies through API deal, shares up 26%
05 Apr 2018
Published by: proactive
Bod Australia obtains improved place in shop window via Australian Pharmaceuticals Industries
05 Apr 2018
Published by: Small Caps
Bod Australia imports first medical cannabis product to Australia
27 Mar 2018
Published by: proactive